Risk factors and early detection of breast cancer: facts, questions, and genome-based perspectives.
作者信息
Ziogas Demosthenes E
出版信息
Curr Oncol. 2012 Jun;19(3):131. doi: 10.3747/co.19.991.
Abstract
摘要
相似文献
1
Risk factors and early detection of breast cancer: facts, questions, and genome-based perspectives.
Curr Oncol. 2012 Jun;19(3):131. doi: 10.3747/co.19.991.
2
Do patients and providers agree about the most important facts and goals for breast reconstruction decisions?
Ann Plast Surg. 2010 May;64(5):563-6. doi: 10.1097/SAP.0b013e3181c01279.
3
Knowledge and practice of breast cancer screening among Jordanian nurses.
Oncol Nurs Forum. 2007 Nov;34(6):1211-7. doi: 10.1188/07.ONF.1211-1217.
4
Development of instruments to measure the quality of breast cancer treatment decisions.
Health Expect. 2010 Sep;13(3):258-72. doi: 10.1111/j.1369-7625.2010.00600.x. Epub 2010 Jun 9.
5
Covering women's greatest health fear: breast cancer information in consumer magazines.
Health Commun. 2011 Apr;26(3):209-20. doi: 10.1080/10410236.2010.546770.
6
Fake facts and alternative truths in medical research.
BMC Med Ethics. 2018 Jan 27;19(1):4. doi: 10.1186/s12910-018-0243-z.
7
Knowledge of breast cancer and its early detection measures among rural women in Akinyele Local Government Area, Ibadan, Nigeria.
BMC Cancer. 2006 Nov 26;6:271. doi: 10.1186/1471-2407-6-271.
8
Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Ont Health Technol Assess Ser. 2010;10(23):1-57. Epub 2010 Dec 1.
9
Anti-angiogenic treatment in breast cancer: Facts, successes, failures and future perspectives.
Cancer Treat Rev. 2017 Feb;53:98-110. doi: 10.1016/j.ctrv.2016.12.009. Epub 2017 Jan 3.
10
Assessing the level of breast cancer awareness among recently diagnosed patients in Ain Shams University Hospital.
Breast. 2013 Dec;22(6):1210-4. doi: 10.1016/j.breast.2013.08.010. Epub 2013 Sep 19.
本文引用的文献
1
Individual genomes and personalized medicine: life diversity and complexity.
Per Med. 2010 Jul;7(4):347-350. doi: 10.2217/pme.10.30.
2
Early-onset breast cancer: what do we know about the risk factors?: A Countercurrents Series.
Curr Oncol. 2011 Oct;18(5):204-5. doi: 10.3747/co.v18i5.938.
3
Genome diagnostics: next-generation sequencing, new genome-wide association studies and clinical challenges.
Expert Rev Mol Diagn. 2011 Sep;11(7):663-6. doi: 10.1586/erm.11.56.
4
Synthetic biology moving into the clinic.
Science. 2011 Sep 2;333(6047):1248-52. doi: 10.1126/science.1206843.
5
Charting a course for genomic medicine from base pairs to bedside.
Nature. 2011 Feb 10;470(7333):204-13. doi: 10.1038/nature09764.
6
Complete genome sequencing and network modeling to overcome trastuzumab resistance.
Pharmacogenomics. 2010 Aug;11(8):1039-43. doi: 10.2217/pgs.10.104.
7
Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice.
Biomark Med. 2010 Aug;4(4):583-6. doi: 10.2217/bmm.10.70.
8
Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management?
Expert Rev Mol Diagn. 2010 Apr;10(3):247-50. doi: 10.1586/erm.10.10.
9
Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine.
Ann Surg Oncol. 2009 Mar;16(3):772-3. doi: 10.1245/s10434-008-0109-6. Epub 2008 Aug 23.
Zotero 插件